FDA Updates

Drug Topics poll: R.Ph.s favor BTC class of drugs

CRN responds to Informed-Choice report calling for transparency in testing dietary supplements

The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine (Xeloda) for patients with metastic or locally advanced breast cancer.

The new products include branded drugs, new formulations, new indications, and new dosing, along with OTCs and home health and beauty items.

Pharmacists' organizations were out in force at a recent FDA hearing on the possibility of creating a third category of drugs that would be placed "behind-the-counter" and pharmacist-assisted.

Rxs for Xenical down since OTC Alli released

Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead

ASHP believes Mevacor is not safe to go over the counter but might be appropriate for behind the counter.

Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead

FDA extends comment period for proposed sunscreen rule

Software manages and tracks every IV dose administered by hospitals

FDA, Bodee LLC issue nationwide recall of Encore Tablets

FDA, Bodee LLC issue nationwide recall of Encore Tablets

New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.

Peggy Memoli is recognized for her work with Alzheimer's patients. She is one of three recipients of 2007 Eisai award recognizing the role of pharmacists in Alzheimer's care.

This drug combines an antihistamine with a nasal decongestant.

Manufacturers are launching new over-the-counter medicines that are innovative.

Two Food and Drug Administration advisory committees voted 13 to 9 to recommend that cough and cold over-the-counter medications not be used for children who are more than two and less than six years old.

At an FDA public meeting to consider whether a behind-the-counter class of drugs should be set up, the agency heard from both supporters and detractors.

APHA adopts policy against feminine hygiene douching practices

FDA requests recall of True Man Sexual Energy, Energy Max dietary supplements.

Adverse event reporting rules for dietary supplements effective Dec. 22.

FDA announces public workshop on OTC drug use among adolescents.

FDA names 15 members for its new Risk Communication Advisory Committee.

Eight pharmacies chosen as Letairis distributors

U.S. Marshals seize more than $300,000 worth of drugs and dietary supplements

NACDS applauds Dextromethorphan Abuse Reduction Act of 2007

Home hygience can help tame MRSA, according to health care providers.